中文 |         ENGLISH

 

Search
Copyright © 2017 ZHEJIANG LEPU PHARMACEUTICAL CO.,LTD.
浙ICP备17026965号 Powered by www.300.cn
Messages | Contact us

Research and development

R & D conditions

The company attaches great importance to technical innovation and technical capacity building, and has built standard laboratory and pilot plant for API and preparations. The laboratory and pilot plant are equipped with corresponding high-end testing equipment, which have strong ability of research and development, technology industrialization and engineering amplification. Main research technique includes: asymmetric synthesis, biological catalytic synthesis, ultra-low temperature reaction, high temperature and high pressure reaction, butyl lithium reaction, borane reduction reaction, ozone oxidation reaction, grignard reaction and catalytic hydrogenation reaction, membrane separation concentration, Resin separation and purification, aseptic crystallization, etc.
 
 
The company has two products included in the national new product trial production, three products included in the national torch plan project, two products included in the national innovation fund project, and three products included in the provincial major science and technology plan project. Many products have won the provincial and municipal science and technology progress prize.
 
 
Among them "the key technology and industrialization of alvastatin calcium chemical - enzymatic synthesis” project was awarded the first prize of Zhejiang scientific and technological progress(picture)." The development and industrialization of high purity norfloxacin and moxifloxacin green synthesis technology "project won the second prize of provincial scientific and technological progress (picture)